 Microbial Sensitivity Tests
"Microbial Sensitivity Tests" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).
| Descriptor ID |
D008826
|
| MeSH Number(s) |
E01.370.225.875.595 E05.200.875.595 E05.337.550.400
|
| Concept/Terms |
Microbial Sensitivity Tests- Microbial Sensitivity Tests
- Microbial Sensitivity Test
- Sensitivity Test, Microbial
- Sensitivity Tests, Microbial
- Test, Microbial Sensitivity
- Tests, Microbial Sensitivity
- Drug Sensitivity Assay, Microbial
Minimum Inhibitory Concentration- Minimum Inhibitory Concentration
- Concentration, Minimum Inhibitory
- Concentrations, Minimum Inhibitory
- Inhibitory Concentration, Minimum
- Inhibitory Concentrations, Minimum
- Minimum Inhibitory Concentrations
Bacterial Sensitivity Tests- Bacterial Sensitivity Tests
- Tests, Bacterial Sensitivity
- Sensitivity Tests, Bacterial
- Test, Bacterial Sensitivity
- Bacterial Sensitivity Test
- Sensitivity Test, Bacterial
|
Below are MeSH descriptors whose meaning is more general than "Microbial Sensitivity Tests".
Below are MeSH descriptors whose meaning is more specific than "Microbial Sensitivity Tests".
This graph shows the total number of publications written about "Microbial Sensitivity Tests" by people in this website by year, and whether "Microbial Sensitivity Tests" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 | | 1997 | 0 | 4 | 4 | | 1998 | 0 | 2 | 2 | | 1999 | 1 | 1 | 2 | | 2001 | 0 | 3 | 3 | | 2002 | 0 | 3 | 3 | | 2003 | 0 | 6 | 6 | | 2004 | 0 | 7 | 7 | | 2005 | 0 | 4 | 4 | | 2006 | 0 | 4 | 4 | | 2007 | 0 | 6 | 6 | | 2008 | 0 | 9 | 9 | | 2009 | 0 | 8 | 8 | | 2010 | 0 | 10 | 10 | | 2011 | 0 | 15 | 15 | | 2012 | 1 | 18 | 19 | | 2013 | 0 | 12 | 12 | | 2014 | 1 | 9 | 10 | | 2015 | 1 | 7 | 8 | | 2016 | 1 | 13 | 14 | | 2017 | 0 | 14 | 14 | | 2018 | 2 | 11 | 13 | | 2019 | 3 | 13 | 16 | | 2020 | 1 | 11 | 12 | | 2021 | 1 | 20 | 21 | | 2022 | 0 | 10 | 10 | | 2023 | 0 | 9 | 9 | | 2024 | 4 | 9 | 13 | | 2025 | 0 | 7 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Microbial Sensitivity Tests" by people in Profiles.
-
Sil M, Goswami A, Mukherjee D, Mukherjee N, Polikarpov I, Goswami A, Nag M, Lahiri D. Withaferin A and Withanolide A-mediated silver nanoparticles target bacterial motility, metabolism, and stress adaptation in E. coli. Nanomedicine. 2025 Aug; 68:102846.
-
Márquez-Friedrichs F, Nolly MB, Ferreyra A, Zuloaga L, Dominguez S, Secotaro A, Rathour VS, Damiani MT, Contreras L, Sánchez DG. Shifts in bla genes and Class 1 integron prevalence in beta-lactamase-producing bacteria before and after the COVID-19 pandemic in Mendoza, Argentina. Microbiol Spectr. 2025 Aug 05; 13(8):e0277124.
-
Singh S, Gumbo T, Wang JY, Boorgula GD, Burke A, Huang HL, McShane PJ, Amaro-Galvez R, Gross JE, Aryal S, Heysell SK, Srivastava S. Imipenem Pharmacokinetics/Pharmacodynamics in Preclinical Hollow Fiber Model, Dose Finding in Virtual Patients, and Clinical Evidence of Efficacy for Mycobacterium abscessus Lung Disease. J Infect Dis. 2025 Jul 11; 231(6):1521-1531.
-
Singh N, Dangi B, Johnson JJ, Louie A, Karunanidhi A, Curry BN, Mitarai S, Daley CL, Hobbie SN, Bulman ZP. Pharmacodynamic assessment of apramycin against Mycobacterium abscessus in a hollow fibre infection model. J Antimicrob Chemother. 2025 May 02; 80(5):1309-1314.
-
Tran SL, Lebreuilly L, Cormontagne D, Samson S, Tô TB, Stosskopf M, Dervyn R, Grießhammer A, de la Cuesta-Zuluaga J, Maier L, Naas T, Mura S, Rognan D, Nicolas J, André G, Ramarao N. An anti-virulence drug targeting the evolvability protein Mfd protects against infections with antimicrobial resistant ESKAPE pathogens. Nat Commun. 2025 Apr 28; 16(1):3324.
-
Kaplan JB, Muzaleva A, Sailer M, Huizinga RB, Kridin K. Synergistic activity of dispersin B and benzoyl peroxide against Cutibacterium acnes/Staphylococcus epidermidis dual-species biofilms. PLoS One. 2025; 20(3):e0320662.
-
Nguyen MH, Calado Nogueira de Moura V, Keepers TR, van Ingen J, Daley CL. In vitro susceptibility of 147 international clinical Mycobacterium abscessus isolates to epetraborole and comparators by broth microdilution. J Antimicrob Chemother. 2025 Mar 03; 80(3):713-716.
-
Ray S, Flemming LK, Scudder CJ, Ly MA, Porterfield HS, Smith RD, Clark AE, Johnson JK, Das S. Comparative phenotypic and genotypic antimicrobial susceptibility surveillance in Achromobacter spp. through whole genome sequencing. Microbiol Spectr. 2025 Apr; 13(4):e0252724.
-
Shin E, Dousa KM, Taracila MA, Bethel CR, Nantongo M, Nguyen DC, Akusobi C, Kurz SG, Plummer MS, Daley CL, Holland SM, Rubin EJ, Bulitta JB, Boom WH, Kreiswirth BN, Bonomo RA. Durlobactam in combination with ß-lactams to combat Mycobacterium abscessus. Antimicrob Agents Chemother. 2025 02 13; 69(2):e0117424.
-
Jia H, Li X, Zhuang Y, Wu Y, Shi S, Sun Q, He F, Liang S, Wang J, Draz MS, Xie X, Zhang J, Yang Q, Ruan Z. Neural network-based predictions of antimicrobial resistance phenotypes in multidrug-resistant Acinetobacter baumannii from whole genome sequencing and gene expression. Antimicrob Agents Chemother. 2024 12 05; 68(12):e0144624.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|